{"companyId":272548,"requestedLanguage":"ja","resolvedLanguage":"ja","availableLanguages":["en","ja"],"companyName":"Cadrenal Therapeutics, Inc.","headOfficeLocation":"822 North A1A, Ponte Vedra, FL 32082, United States","presidentName":"Quang Pham","companySummary":null,"stockCode":"CVKD","currency":"USD","capital":null,"sales":null,"employees":null,"employeesConsolidated":null,"humanCheck":false,"domains":["cadrenal.com"],"businessContents":["生命を脅かす免疫および血栓症の治療法を開発しています。","心腎疾患および凝固障害の臨床段階の治療法を開発しています。"],"relations":[],"dataSources":[{"detailNumber":1,"url":"https://www.cadrenal.com/about-us/","scoreAbout":500,"scoreBusiness":0,"scoreGroup":0,"scoreCustomer":0}]}